Difference between revisions of "Part:BBa K3140003"
Line 90: | Line 90: | ||
[[Image:T--Sydney_Australia--baeo16_387_lcms.png|frame|none|'''Fig. 5''': Mass spectra obtained LC/MS of protein extract of ''E. coli'' DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine. A peak at m/z = 271.08422 with chemical formula C10H14N2O4P was identified, matching PsiK product norbaeocystin.]] | [[Image:T--Sydney_Australia--baeo16_387_lcms.png|frame|none|'''Fig. 5''': Mass spectra obtained LC/MS of protein extract of ''E. coli'' DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine. A peak at m/z = 271.08422 with chemical formula C10H14N2O4P was identified, matching PsiK product norbaeocystin.]] | ||
+ | |||
+ | Finally, we were able to confirm the identity of PsiM on a polyacrylamide gel ('''Fig. 6''') using peptide mass fingerprinting. | ||
+ | |||
+ | [[Image:T--Sydney_Australia--peptide_gel.jpg|frame|none|'''Fig. 6''': Polyacrylamide gel prepared for peptide mass fingerprinting.]] | ||
+ | |||
+ | |||
Given these results, we conclude that we have successfully expressed the norbaeocystin methyltransferase PsiM from ''Psilocybe cubensis'' in ''Escherichia coli'' ''in vivo''. | Given these results, we conclude that we have successfully expressed the norbaeocystin methyltransferase PsiM from ''Psilocybe cubensis'' in ''Escherichia coli'' ''in vivo''. | ||
− | <span class='h3bb'>Sequence and Features</span> | + | <span class='h3bb'>'''Sequence and Features'''</span> |
<partinfo>BBa_K3140003 SequenceAndFeatures</partinfo> | <partinfo>BBa_K3140003 SequenceAndFeatures</partinfo> | ||
Revision as of 06:25, 20 October 2019
PsiM - Norbaeocystin methyltransferase from Psilocybe cubensis
PsiM is a norbaeocystin methyltransferase, which catalyses the conversion of norbaeocystin to psilocybin.
- NCBI: ASU62238.1
- UniProt: P0DPA9
- EC number: 2.1.1.345
Usage and Biology
The mechanism of psilocybin biosynthesis in Psilocybe sp. was recently elucidated by Fricke et al.[1], demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin.
PsiM is a native enzyme obtained from Psilocybe cubensis, which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts norbaeocystin as a substrate to yield psilocybin through N,N-dimethylation (Fig. 1). In a native state, PsiM is a 309 amino acid protein (34.4 kDa) with a theoretical pI of 4.96 calculated with the ExPASy ProtParam tool[2].
Heterologous expression of PsiM has been achieved in a T7 induction system using pET-28c(+) transformed into Escherichia coli BL21(DE3), co-transformed with chaperone plasmid pGro7 (Fig. 2), resulting in a 345 amino acid polypeptide, with a computed molecular weight of 38.2 kDa.
A band consistent with expression of PsiM in cells induced with IPTG was observed on polyacrylamide gel electrophoresis (Fig. 3).
In vivo expression of PsiM was confirmed by LC/MS. PsiD, PsiK, and PsiM were cloned into a pUS250 backbone as a gene cluster using Golden Gate cloning, yielding pUS387 (Fig. 4). Expression in pUS387 is driven by a class 1 integron gene cassette Pc promoter controlled by a cumate induction system. E. coli DH5α cells co-transformed with pUS387 and pGro7 were cultured in terrific broth (TB) supplemented with 4-hydroxytryptamine. Whole cell culture was subject to LC/MS.
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
0.56 | 23.2 | 271.0817 | C12H15O7 | unknown |
1.16 | 12.4 | 257.0689 | C10H14N2O4P | norbaeocystin |
1.9 | 0.9 | 271.0844 | C11H16N2O4P | baeocystin |
2.75 | 5.2 | 177.1023 | C10H13N2O | hydroxytryptamine |
5.08 | 6.4 | 205.0972 | C11H13N2O2 | tryptophan |
5.82 | 6.4 | 161.1074 | C10H13N2 | tryptamine |
10.15 | 14.4 | 285.1335 | C14H21O6 | unknown |
10.15 | 14.4 | 285.1335 | C9H18N8OP | unknown |
While in vitro activity of PsiM could not be conducted due to the lack of availability of reagent norbaeocystin, the in vivo activity of PsiM is confirmed by observation of PsiM product baeocystin (Fig. 5).
Finally, we were able to confirm the identity of PsiM on a polyacrylamide gel (Fig. 6) using peptide mass fingerprinting.
Given these results, we conclude that we have successfully expressed the norbaeocystin methyltransferase PsiM from Psilocybe cubensis in Escherichia coli in vivo.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]